bicalutamide has been researched along with serine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, S; Beaudoin, C; Communal, Y; Leotoing, L; Manin, M; Morel, L; Veyssiere, G | 1 |
| Black, BE; Eblen, ST; Gioeli, D; Gordon, V; Kesler, CT; Paschal, BM; Spencer, A; Weber, MJ | 1 |
| Beggs, RE; Bose, S; Crapuchettes, ME; D'Abronzo, LS; deVere White, RW; Durbin-Johnson, BP; Ghosh, PM; Melgoza, FU; Mudryj, M; Siddiqui, S; Tepper, CG; Vinall, RL | 1 |
3 other study(ies) available for bicalutamide and serine
| Article | Year |
|---|---|
Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells.
Topics: Anilides; Animals; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cycloheximide; Dose-Response Relationship, Drug; Enzyme Activation; Epithelial Cells; Escherichia coli; Glutathione Transferase; Humans; Ligands; Mice; Models, Genetic; Nitriles; Phosphatidylinositol 3-Kinases; Phosphorylation; Plasmids; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Serine; Signal Transduction; Threonine; Time Factors; Tosyl Compounds; Transcription, Genetic; Transfection | 2004 |
Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.
Topics: Active Transport, Cell Nucleus; Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; MAP Kinase Kinase 6; Mutation; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Kinases; Receptors, Androgen; Serine; Signal Transduction; Stress, Physiological; Tosyl Compounds; Transcription, Genetic | 2006 |
The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
Topics: Anilides; Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line, Tumor; Eukaryotic Initiation Factor-4E; Everolimus; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Nude; Nitriles; Phosphorylation; Prostatic Neoplasms, Castration-Resistant; Protein Serine-Threonine Kinases; Purines; Receptors, Androgen; Serine; Sirolimus; TOR Serine-Threonine Kinases; Tosyl Compounds; Xenograft Model Antitumor Assays | 2017 |